Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Articles|February 25, 2022
Daily OTC Pearl: Coricidin
Coricidin is a decongestant-free treatment indicated for relief of the symptoms of a cold in patients with high blood pressure.
Advertisement
OTC/Lifestyle Pearl of the Day: Coricidin
Indication: Coricidin is a decongestant-free treatment indicated for relief of fever, runny nose, sneezing, body ache, headache, and sore throat in patients with high blood pressure.
Insight:
- Active ingredients: Acetaminophen 325 mg for pain reliever/fever reducer, chlorpheniramine maleate 2 mg as an antihistamine.
- Warning: Liver toxicity—this product contains acetaminophen. Severe liver damage may occur if you take more than 4000 mg of acetaminophen in 24 hours.
- Directions: Do not take more than the recommended dose. Take 2 tablets with water every 4-6 hours. Do not exceed 10 tablets in 24 hours or as directed by a physician.
- Children under 12 years of age should not use.
- Storage: Store between 20º to 25ºC (68º to 77ºF)
Sources:
Advertisement
Related to this article
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Fall 2026 Quiz: Test Your Pharmacy Knowledge!
5